Albert C. Ludolph
Albert Einstein Allee 11
Ulm, BW 89081, Germany
Ulm, BW 89081, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 632 publications
Author Correction: FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis.
Journal: Nature neuroscience
Published: July 16, 2026
Innate immune signaling as a potential pathomechanistic biomarker for distinct subtypes in amyotrophic lateral sclerosis.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: June 15, 2026
Blood SOD1 Activity in ALS Patients Receiving Tofersen Treatment.
Journal: Annals of neurology
Published: April 22, 2026
ALS motor phenotypes: a revised 'OPM' classification.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: March 17, 2026
Incidence and Survival Rates of Frontotemporal Lobar Degeneration: Population-Based Registry Study.
Journal: Neurology
Published: February 23, 2026
Long-Term Tofersen in SOD1 Amyotrophic Lateral Sclerosis.
Journal: JAMA neurology
Published: February 09, 2026
Thyroid hormones and energy metabolism in amyotrophic lateral sclerosis.
Journal: Brain communications
Published: December 19, 2025
FUS controls muscle differentiation through phase separation-mediated recruitment of the transcription factors MEF2 and ETV5.
Journal: The EMBO journal
Published: November 05, 2025
Uncovering hypothalamic network disruption in ALS.
Journal: Journal of neurology
Published: November 03, 2025
Increased transmembrane protein 119 (TMEM119) levels in the cerebrospinal fluid of patients with mild cognitive impairment due to Alzheimer's disease suggest early microglial involvement.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: July 12, 2025
Last Updated: 09/26/2026